# A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

> **NCT00747526** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 51 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)

## Interventions

- **DRUG:** Rabeprazole sodium 5 mg
- **DRUG:** Rabeprazole sodium 10 mg

## Key facts

- **NCT ID:** NCT00747526
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00747526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00747526, "A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00747526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*